164 related articles for article (PubMed ID: 37713839)
1. Mitochondrial metabolism-related signature depicts immunophenotype and predicts therapeutic response in testicular germ cell tumors.
Qiu D; Gao L; Zhang S; Lin G; Yu X
Medicine (Baltimore); 2023 Sep; 102(37):e35120. PubMed ID: 37713839
[TBL] [Abstract][Full Text] [Related]
2. A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors.
Gao F; Xu Q; Jiang Y; Lu B
Sci Rep; 2023 Mar; 13(1):3759. PubMed ID: 36882567
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration.
Luo Y; Zhou Q; Zhu F; Fan L; Bo H; Wang X
Bioengineered; 2021 Dec; 12(2):11288-11302. PubMed ID: 34882061
[TBL] [Abstract][Full Text] [Related]
5. [Molecular Pathogenesis of Testicular Germ Cell Tumors].
Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L
Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor.
Guo J; Wang S; Jiang Z; Tang L; Liu Z; Cao J; Hu Z; Chen X; Luo Y; Bo H
Front Immunol; 2022; 13():859730. PubMed ID: 35669771
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
8. Identification of new biomarkers in immune microenvironment of testicular germ cell tumour.
Song Y; Qi X; Kang J; Wang X; Ou N; Zhu J; Wang S; Liu X
Andrologia; 2021 Apr; 53(3):e13986. PubMed ID: 33544925
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
Wu H; Zhang Z; Xiao XY; Zhang ZY; Gao SL; Lu C; Zuo L; Zhang LF
Bioengineered; 2021 Dec; 12(1):1939-1951. PubMed ID: 34002664
[TBL] [Abstract][Full Text] [Related]
10. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract][Full Text] [Related]
12. Identification of mRNA Prognostic Markers for TGCT by Integration of Co-Expression and CeRNA Network.
Zhu F; Liu Z; Zhou Q; Fan J; Zhou D; Xing L; Bo H; Tang L; Fan L
Front Endocrinol (Lausanne); 2021; 12():743155. PubMed ID: 34621245
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.
Li L; Hu Y; Li X; Ju B
Medicine (Baltimore); 2024 Apr; 103(15):e37688. PubMed ID: 38608099
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia.
Tong X; Zhou F
Front Immunol; 2023; 14():1120670. PubMed ID: 37138869
[TBL] [Abstract][Full Text] [Related]
15. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
[TBL] [Abstract][Full Text] [Related]
16. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing.
Yao X; Zhou H; Duan C; Wu X; Li B; Liu H; Zhang Y
Front Immunol; 2022; 13():1096494. PubMed ID: 36713456
[TBL] [Abstract][Full Text] [Related]
18. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
[TBL] [Abstract][Full Text] [Related]
19. METTL3 May Regulate Testicular Germ Cell Tumors Through EMT and Immune Pathways.
Luo Y; Sun Y; Li L; Mao Y
Cell Transplant; 2020; 29():963689720946653. PubMed ID: 32749150
[TBL] [Abstract][Full Text] [Related]
20.
Liu Z; Fang B; Cao J; Zhou Q; Zhu F; Fan L; Xue L; Huang C; Bo H
Bioengineered; 2022 May; 13(5):12141-12155. PubMed ID: 35575252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
